Seyed‐Mohammad Fereshtehnejad
Seyed‐Mohammad Fereshtehnejad publishes mostly in Neurology, Psychiatry and Mental health and Epidemiology, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Dementia and Cognitive Impairment Research.
- World rank
- #152,829 of 7,710,434 ranked researchers
- Rank in Sweden
- #1,562 of 71,437
- Works
- 342
- Citations
- 128k
- Citations per work
- 373.0
What does Seyed‐Mohammad Fereshtehnejad research?
Seyed‐Mohammad Fereshtehnejad's work is mostly in Medicine (42%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else19757.6%
- Health Sciences14542.4%
- Medicine14542.4%
- 1Neurology17% of their works
- 2Psychiatry and Mental health6% of their works
- 3Epidemiology6% of their works
- 4Surgery5% of their works
- 5Physiology5% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Dementia and Cognitive Impairment Research
- Global Maternal and Child Health
- Restless Legs Syndrome Research
- Health disparities and outcomes
- Alzheimer's disease research and treatments
- Insurance, Mortality, Demography, Risk Management
Which keywords describe Seyed‐Mohammad Fereshtehnejad's research?
The keywords of their largest research topics: Parkinson's Disease, Diagnostic Criteria, Neurodegeneration, Oxidative Stress, a-Synuclein, Dopaminergic Neurons, Neurological Disorders and Deep Brain Stimulation.
- Population Ageing
- Amyloid Hypothesis
- Social Relationships
- Epidemiology
- Child Mortality
- Alzheimer's Disease
- Deep Brain Stimulation
- a-Synuclein
- Oxidative Stress
- Diagnostic Criteria
- Parkinson's Disease
- Neurodegeneration
- Dopaminergic Neurons
- Neurological Disorders
- Subthalamic Nucleus
- Mild Cognitive Impairment
- Maternal Mortality
- Restless Legs Syndrome
- Socioeconomic Inequalities
- Mortality Forecasting
- Tau Pathology
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Parkinson's Disease1182 topics
- Diagnostic Criteria992 topics
- Neurodegeneration982 topics
- Oxidative Stress982 topics
- Dopaminergic Neurons821 topic
- a-Synuclein821 topic
- Neurological Disorders532 topics
- Deep Brain Stimulation361 topic
- Subthalamic Nucleus361 topic
- Alzheimer's Disease351 topic
- Mild Cognitive Impairment351 topic
- Child Mortality191 topic
- Maternal Mortality191 topic
- Epidemiology171 topic
- Restless Legs Syndrome171 topic
- Social Relationships171 topic
- Socioeconomic Inequalities171 topic
- Amyloid Hypothesis161 topic
- Mortality Forecasting161 topic
- Population Ageing161 topic
- Tau Pathology161 topic
Where does Seyed‐Mohammad Fereshtehnejad work?
Seyed‐Mohammad Fereshtehnejad's main affiliation in the publication record is Karolinska Institutet, Sweden.
How many publications and citations does Seyed‐Mohammad Fereshtehnejad have?
OpenAlex counts 342 works and 127,555 citations for Seyed‐Mohammad Fereshtehnejad, an h-index of 67, ranking #152,829 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Seyed‐Mohammad Fereshtehnejad
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Seyed‐Mohammad Fereshtehnejad. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.